[Remote] Representante de Ventas Línea Cardiometabólico at Eli Lilly and Company

Colombia

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Farmacéutica, SaludIndustries

Requirements

  • Professionals in administrative areas with experience in medical visits, or health professionals (Doctors, Nurses, Pharmaceutical Chemists, etc.) with passion for patients and interest in commercial and business areas
  • Skills for data analysis, interpretation, and decision-making based on information
  • Deep knowledge of the Health System
  • Flexibility, adaptability to change, winning attitude, and desire to develop in the corporate sector focused on improving patients' lives
  • Desirable: Postgraduate studies, intermediate English level with high comprehension of scientific literature in English, commercial experience or in the pharmaceutical industry

Responsibilities

  • Deeply know the scientific bases of innovative medications and constantly disclose them to specialists (Endocrinologists, cardiologists, diabetologists, internists, nephrologists, and others) to benefit patients
  • Implement the marketing strategy and achieve impact on key clients through a multichannel strategy
  • Identify and appropriately address potential clinical, administrative, and economic barriers that may hinder prescription or patient access to treatments
  • Deeply know the health market, including main actors (EPS, IPS, distribution chain), disease stages, and treatment protocols/guides used by doctors
  • Build and establish high-quality relationships with different stakeholders of the institutions in charge
  • Prioritize territory opportunities, develop action plans, and ensure their implementation to achieve established objectives
  • Know and comply with Lilly's processes, policies, and procedures to perform the role within the highest standards of compliance and ethics

Skills

Ventas Farmacéuticas
Conocimiento Científico Medicamentos
Estrategia Multicanal
Gestión Stakeholders
Mercadeo Salud
Diabetes
Cardiometabólico
Endocrinología
Cardiología
Nefrología

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI